Contributions of Depressive Mood and Circulating Inflammatory Markers to Coronary Heart Disease in Healthy European Men

Ovid Technologies (Wolters Kluwer Health) - Tập 111 Số 18 - Trang 2299-2305 - 2005
Jean‐Philippe Empana1,2,3,4,5,6,7,8,9,10, D.H. Sykes11,1,2,3,4,6,7,8,9,10, G. Luc1,2,3,4,12,6,7,8,9,10, I. Juhan‐Vague1,2,3,4,13,6,7,8,9,10, Dominique Arveiler14,1,2,3,4,6,7,8,9,10, Jean Ferrières1,2,3,4,15,6,7,8,9,10, Philippe Amouyel1,2,3,4,6,16,7,8,9,10, A. Bingham17,1,2,3,4,6,7,8,9,10, M Montayé1,2,3,4,6,18,7,8,9,10, J.B. Ruidavets1,2,3,4,19,6,7,8,9,10, B. Haas20,1,2,3,4,6,7,8,9,10, A. Evans21,1,2,3,4,6,7,8,9,10, Xavier Jouven1,2,3,4,6,7,8,9,10,22, Pierre Ducimetière1,2,3,4,6,23,7,8,9,10
1Department of Atherosclerosis, SERLIA-INSERM UR325, Institut Pasteur de Lille, Lille, France (G.L.)
2Department of Cardiology, European Hospital G Pompidou, Paris, France (X.J.).
3Department of Hematology, Faculty of Medicine, INSERM U626, Marseilles, France (I.J.-V.)
4From INSERM Avenir, Epidemiology of Sudden Death in the Population, Villejuif, France (J.P.E., X.J.); France MONICA Project Coordinating Centre, INSERM U258, Paul Brousse Hospital, Villejuif, France (J.P.E., A.B., X.J., P.D.); School of Psychology (D.H.S.) and Department of Epidemiology and Public Health (A.E.), Queen’s University, Belfast, Northern Ireland; Queen’s University, Belfast, Northern Ireland (D.H.S.); Department of Atherosclerosis, SERLIA-INSERM UR325, Institut Pasteur de Lille, Lille,...
5J.P. Empana From INSERM Avenir, Epidemiology of Sudden Death in the Population, Villejuif, France (J.P.E., X.J.)
6Lille MONICA Project, INSERM U508, Institut Pasteur de Lille, Lille, France (P.A., M.M.)
7Queen's University, Belfast, Northern Ireland (D.H.S.)
8School of Psychology (D.H.S.) and Department of Epidemiology and Public Health (A.E.), Queen's University, Belfast, Northern Ireland
9Strasbourg MONICA Project, Department of Epidemiology and Public Health, Faculty of Medicine, Strasbourg, France (D.A., B.H.)
10Toulouse MONICA Project, INSERM U558, Purpan University, Toulouse, France (J.F., J.B.R.)
11D.H. Sykes From INSERM Avenir, Epidemiology of Sudden Death in the Population, Villejuif, France (J.P.E., X.J.)
12G. Luc From INSERM Avenir, Epidemiology of Sudden Death in the Population, Villejuif, France (J.P.E., X.J.)
13I. Juhan-Vague From INSERM Avenir, Epidemiology of Sudden Death in the Population, Villejuif, France (J.P.E., X.J.)
14D. Arveiler From INSERM Avenir, Epidemiology of Sudden Death in the Population, Villejuif, France (J.P.E., X.J.)
15J. Ferrieres From INSERM Avenir, Epidemiology of Sudden Death in the Population, Villejuif, France (J.P.E., X.J.)
16P. Amouyel From INSERM Avenir, Epidemiology of Sudden Death in the Population, Villejuif, France (J.P.E., X.J.)
17A. Bingham From INSERM Avenir, Epidemiology of Sudden Death in the Population, Villejuif, France (J.P.E., X.J.)
18M. Montaye From INSERM Avenir, Epidemiology of Sudden Death in the Population, Villejuif, France (J.P.E., X.J.)
19J.B. Ruidavets From INSERM Avenir, Epidemiology of Sudden Death in the Population, Villejuif, France (J.P.E., X.J.)
20B. Haas From INSERM Avenir, Epidemiology of Sudden Death in the Population, Villejuif, France (J.P.E., X.J.)
21A. Evans From INSERM Avenir, Epidemiology of Sudden Death in the Population, Villejuif, France (J.P.E., X.J.)
22X. Jouven From INSERM Avenir, Epidemiology of Sudden Death in the Population, Villejuif, France (J.P.E., X.J.)
23P. Ducimetiere From INSERM Avenir, Epidemiology of Sudden Death in the Population, Villejuif, France (J.P.E., X.J.)

Tóm tắt

Background— Data on the possible association between depressive disorders and inflammatory markers are scarce and inconsistent. We investigated whether subjects with depressive mood had higher levels of a wide range of inflammatory markers involved in coronary heart disease (CHD) incidence and examined the contribution of these inflammatory markers and depressive mood to CHD outcome.

Methods and Results— We built a nested case-referent study within the Prospective Epidemiological Study of Myocardial Infarction (PRIME) study of healthy middle-aged men from Belfast and France. We considered the baseline plasma sample from 335 future cases (angina pectoris, nonfatal myocardial infarction, coronary death) and 670 matched controls (2 controls per case). Depressive mood characterized men whose baseline depression score (13-item modification of the Welsh depression subscale) was in the fourth quartile (mean score, 5.75; range, 4 to 12). On average, men with depressive mood had 46%, 16%, and 10% higher C-reactive protein, interleukin-6, and intercellular adhesion molecule-1 levels, respectively, independently of case-control status, social characteristics, and classic cardiovascular risk factors; no statistical difference was found for fibrinogen. The odds ratios of depressive mood for CHD were 1.35 (95% CI, 1.05 to 1.73) in univariate analysis and 1.50 (95% CI, 1.04 to 2.15) after adjustment for social characteristics and classic cardiovascular risk factors. The latter odds ratio remained unchanged when each inflammatory marker was added separately, and in this analysis, each inflammatory marker contributed significantly to CHD event risk.

Conclusions— These data support an association of depressive mood with inflammatory markers and suggest that depressive mood is related to CHD even after adjustment for these inflammatory markers.

Từ khóa


Tài liệu tham khảo

10.1097/00001648-199307000-00003

10.1001/archinte.158.13.1422

10.1161/circ.94.12.3123

10.1161/circ.93.11.1976

10.1001/archinte.160.9.1261

10.1097/01.PSY.0000058371.50240.E3

10.1016/S0749-3797(02)00439-7

10.1056/NEJM199901143400207

10.1161/circ.105.9.1135

10.1161/circ.99.2.237

10.1161/01.atv.0000079512.66448.1d

10.1016/S0140-6736(97)09032-6

10.1016/S0021-9150(03)00280-6

10.1097/00001648-200301000-00025

10.1001/archinte.164.9.1010

10.1016/S0002-9149(02)02863-1

10.1111/j.1532-5415.1999.tb01894.x

10.1016/S0006-3223(02)01811-5

10.1016/j.ehj.2004.01.018

10.1016/S0002-9149(01)02264-0

10.1017/S0033291702007250

10.1136/heart.88.5.521

10.1016/S0002-9149(01)01623-X

10.1093/qjmed/91.10.667

10.1093/ije/30.5.1057

10.1093/ije/31.6.1227

10.1002/bs.3830160508

10.1016/S0021-9150(99)00463-3

10.1161/circ.103.15.1933

10.1176/appi.ajp.161.2.271

10.1055/s-0037-1616754